JP2010540593A5 - - Google Patents

Download PDF

Info

Publication number
JP2010540593A5
JP2010540593A5 JP2010527450A JP2010527450A JP2010540593A5 JP 2010540593 A5 JP2010540593 A5 JP 2010540593A5 JP 2010527450 A JP2010527450 A JP 2010527450A JP 2010527450 A JP2010527450 A JP 2010527450A JP 2010540593 A5 JP2010540593 A5 JP 2010540593A5
Authority
JP
Japan
Prior art keywords
disease
asthma
dermatitis
syndrome
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010527450A
Other languages
English (en)
Japanese (ja)
Other versions
JP5727223B2 (ja
JP2010540593A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/063185 external-priority patent/WO2009043890A1/en
Publication of JP2010540593A publication Critical patent/JP2010540593A/ja
Publication of JP2010540593A5 publication Critical patent/JP2010540593A5/ja
Application granted granted Critical
Publication of JP5727223B2 publication Critical patent/JP5727223B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010527450A 2007-10-04 2008-10-01 オキサジアゾール・ジアリール化合物 Expired - Fee Related JP5727223B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP07117925 2007-10-04
EP07117925.3 2007-10-04
US99813607P 2007-10-09 2007-10-09
US60/998,136 2007-10-09
PCT/EP2008/063185 WO2009043890A1 (en) 2007-10-04 2008-10-01 Oxadiazole diaryl compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014197234A Division JP2015025001A (ja) 2007-10-04 2014-09-26 オキサジアゾール・ジアリール化合物

Publications (3)

Publication Number Publication Date
JP2010540593A JP2010540593A (ja) 2010-12-24
JP2010540593A5 true JP2010540593A5 (enExample) 2013-10-24
JP5727223B2 JP5727223B2 (ja) 2015-06-03

Family

ID=38961274

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010527450A Expired - Fee Related JP5727223B2 (ja) 2007-10-04 2008-10-01 オキサジアゾール・ジアリール化合物
JP2014197234A Withdrawn JP2015025001A (ja) 2007-10-04 2014-09-26 オキサジアゾール・ジアリール化合物
JP2016100693A Expired - Fee Related JP6224771B2 (ja) 2007-10-04 2016-05-19 オキサジアゾール・ジアリール化合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014197234A Withdrawn JP2015025001A (ja) 2007-10-04 2014-09-26 オキサジアゾール・ジアリール化合物
JP2016100693A Expired - Fee Related JP6224771B2 (ja) 2007-10-04 2016-05-19 オキサジアゾール・ジアリール化合物

Country Status (15)

Country Link
US (2) US8404676B2 (enExample)
EP (1) EP2193126B1 (enExample)
JP (3) JP5727223B2 (enExample)
KR (1) KR20100083814A (enExample)
CN (2) CN104478821B (enExample)
AR (1) AR068730A1 (enExample)
AU (1) AU2008306886B2 (enExample)
BR (1) BRPI0817597A2 (enExample)
CA (1) CA2696829C (enExample)
EA (1) EA201070423A1 (enExample)
ES (1) ES2547877T3 (enExample)
IL (1) IL204520A (enExample)
MX (1) MX2010003614A (enExample)
WO (1) WO2009043890A1 (enExample)
ZA (1) ZA201001217B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2125797T3 (da) 2007-03-16 2014-02-10 Actelion Pharmaceuticals Ltd Aminopyridinderivater som s1p1/edg1-receptoragonister
CN101970420B (zh) 2007-10-04 2014-09-24 默克雪兰诺有限公司 噁二唑衍生物
US8404676B2 (en) * 2007-10-04 2013-03-26 Merck Serono Sa Oxadiazole diaryl compounds
US8551463B2 (en) 2007-10-22 2013-10-08 Living Proof, Inc. Hair care compositions and methods of treating hair
EP2250165B1 (en) * 2007-12-21 2018-07-25 Merck Serono S.A. Triazole oxadiazoles derivatives
CN101965345B (zh) * 2008-03-06 2014-05-28 埃科特莱茵药品有限公司 吡啶化合物
MX2010009645A (es) 2008-03-07 2010-09-28 Actelion Pharmaceuticals Ltd Derivados novedosos de aminometil benceno.
ES2405054T3 (es) 2009-01-23 2013-05-30 Bristol-Myers Squibb Company Derivados de pirazol-1,2,4-oxadiazol como agonistas de esfingosina-1-fosfato
EP2389377B1 (en) 2009-01-23 2014-07-16 Bristol-Myers Squibb Company Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
WO2010085581A1 (en) 2009-01-23 2010-07-29 Bristol-Myers Squibb Company Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
TWI410421B (zh) 2009-07-16 2013-10-01 Actelion Pharmaceuticals Ltd 吡啶-4-基衍生物
US8399451B2 (en) 2009-08-07 2013-03-19 Bristol-Myers Squibb Company Heterocyclic compounds
JP5735634B2 (ja) 2010-04-23 2015-06-17 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company スフィンゴシン−1−リン酸受容体1アゴニストとしての4−(5−イソオキサゾリルまたは5−ピラゾリル−1,2,4−オキサジアゾール−3−イル)−マンデル酸アミド化合物
ES2515415T3 (es) * 2010-04-27 2014-10-29 Allergan, Inc. Derivados de 3-(4-((1H-imidazol-1-il)metil)fenil)-5-aril-1,2,4-oxadiazol como moduladores de receptores de la esfingosina-1-fosfato
WO2012040532A1 (en) * 2010-09-24 2012-03-29 Bristol-Myers Squibb Company Substituted oxadiazole compounds and their use as s1p1 agonists
CA2818470C (en) 2011-01-19 2019-03-05 Actelion Pharmaceuticals Ltd 2-methoxy-pyridin-4-yl derivatives
US9073881B2 (en) * 2011-09-23 2015-07-07 Hoffmann-La Roche Inc. Benzoic acid derivatives
ES2770348T3 (es) 2015-05-20 2020-07-01 Idorsia Pharmaceuticals Ltd Forma cristalina del compuesto (s)-3-{4-[5-(2-ciclopentil-6-metoxi-piridin-4-il)-[1,2,4]oxadiazol-3-il]-2-etil-6-metil-fenoxi}-propano-1,2-diol
CA3201000A1 (en) * 2020-11-09 2022-05-12 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the s1p1 receptor
EP4050002A1 (en) * 2021-02-26 2022-08-31 First Health Pharmaceuticals B.V. Anti-proliferative agents

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH623971B5 (de) 1976-06-04 1982-01-15 Hoechst Ag Verfahren zur herstellung neuer benzofuranderivate und deren verwendung als optische aufheller.
US4135910A (en) 1977-05-12 1979-01-23 Monsanto Company Oxadiazol-3-yl-benzoates as plant growth regulants
DE4320801A1 (de) 1993-06-23 1995-01-05 Fahlberg List Pharma Gmbh 2-Hydroxyphenylsubstituierte 1,2,4-Triazole und 1,2,4-Oxadiazole, ihre Verwendung als pharmazeutische Wirkstoffe und sie enthaltende Arzneimittel
DE19643037A1 (de) * 1996-10-18 1998-04-23 Boehringer Ingelheim Kg Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
AUPP999799A0 (en) 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
EP4101846B1 (en) 2003-04-11 2023-08-02 PTC Therapeutics, Inc. 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
CA2524867A1 (en) * 2003-05-15 2004-12-02 Merck & Co., Inc. 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
WO2005032465A2 (en) 2003-10-01 2005-04-14 Merck & Co., Inc. 3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
US7605171B2 (en) 2003-12-17 2009-10-20 Merck & Co., Inc. (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists
WO2005108370A1 (ja) * 2004-04-16 2005-11-17 Ajinomoto Co., Inc. ベンゼン化合物
EP1758579A1 (en) 2004-05-29 2007-03-07 7TM Pharma A/S Crth2 receptor ligands for medicinal uses
CA2583681A1 (en) * 2004-10-22 2006-05-04 Merck & Co., Inc. 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists
US20080306124A1 (en) 2005-06-08 2008-12-11 Rainer Albert Polycyclic Oxadiazoles or I Soxazoles and Their Use as Sip Receptor Ligands
CA2623327A1 (en) 2005-10-07 2007-04-19 Kissei Pharmaceutical Co., Ltd. Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
TWI404706B (zh) * 2006-01-11 2013-08-11 Actelion Pharmaceuticals Ltd 新穎噻吩衍生物
JP2009269819A (ja) 2006-08-25 2009-11-19 Asahi Kasei Pharma Kk アミン化合物
CN101522646A (zh) 2006-09-29 2009-09-02 诺瓦提斯公司 具有抗炎和免疫抑制特性的二唑衍生物
RU2009127095A (ru) 2006-12-15 2011-01-20 Эбботт Лэборетриз (Us) Новые оксадиазольные соединения
EP2014653A1 (en) 2007-06-15 2009-01-14 Bioprojet Novel dicarboxylic acid derivatives as S1P1 receptor agonists
US8404676B2 (en) * 2007-10-04 2013-03-26 Merck Serono Sa Oxadiazole diaryl compounds
CN101970420B (zh) 2007-10-04 2014-09-24 默克雪兰诺有限公司 噁二唑衍生物

Similar Documents

Publication Publication Date Title
JP6506836B2 (ja) B型肝炎ウイルス感染症の処置および予防のための新規ピリダゾンおよびトリアジノン
JP7787063B2 (ja) オーロラキナーゼ阻害剤およびその使用
JP2007515432A5 (enExample)
JP2006528980A5 (enExample)
JP2002528493A5 (enExample)
KR102212975B1 (ko) 피리딘-4-일 유도체
JP2009534407A5 (enExample)
JP2009535307A5 (enExample)
JP2008517915A5 (enExample)
ES2548258T3 (es) Compuestos de oxadiazol sustituidos y su uso como agonistas de S1P1
JP2019533696A (ja) B型肝炎ウイルス感染症の処置及び予防のための新規なテトラヒドロピリドピリミジン
JP2015535832A5 (enExample)
JP2013514980A5 (enExample)
JP2009532417A5 (enExample)
TW200806652A (en) N-hydroxyacrylamide compounds
JP2007522142A5 (enExample)
JP2018509438A5 (enExample)
JP6781848B2 (ja) 新規なピロロピリジン誘導体、その製造方法及び用途
HRP20211121T1 (hr) Supstituirani biciklični spojevi
WO2023169572A1 (zh) 一种三嗪类化合物、其中间体、其制备方法及其用途
JP2007503432A5 (enExample)
JP3539926B2 (ja) 抗ウイルス性ピリミジンジオン誘導体及びそれらの製造方法
EP3239160A1 (en) Tizoxanide phosphate and alkane sulfonate and pharmaceutical applications thereof
JP2025513716A5 (enExample)
JP2006507347A5 (enExample)